Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00660127 · ClinicalTrials.gov registry record
The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 25
- Enrollment target
NCT00660127: Completed study, sponsored by Wake Forest University Health Sciences.
NCT00660127 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00660127 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this research study is to assess whether seeing other people itch affects itch perception in patients with atopic dermatitis and healthy subjects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-12 |
What the finished NCT00660127 record still lists
NCT00660127 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00660127 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00660127 about?
NCT00660127 is a clinical study titled "The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients". The purpose of this research study is to assess whether seeing other people itch affects itch perception in patients with atopic dermatitis and healthy subjects.
What is the current status of trial NCT00660127?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2007-10. Estimated completion is 2009-12.
Who is sponsoring clinical trial NCT00660127?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia